Patents by Inventor Geoffrey Erickson

Geoffrey Erickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230280346
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer
    Type: Application
    Filed: February 20, 2023
    Publication date: September 7, 2023
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Patent number: 11585814
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: February 21, 2023
    Assignee: IMMUNIS.AI, INC.
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Publication number: 20200332366
    Abstract: This invention provides a set of biological markers that are useful for detecting cancer. This invention further provides methods of using those biological markers for the diagnosis, prognosis, or monitoring of cancer.
    Type: Application
    Filed: December 2, 2019
    Publication date: October 22, 2020
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wonjo
  • Publication number: 20200318201
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer
    Type: Application
    Filed: April 20, 2020
    Publication date: October 8, 2020
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Patent number: 10626464
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: April 21, 2020
    Assignee: Cell MDX, LLC
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Publication number: 20200040404
    Abstract: The present invention relates to compositions and methods for assessing prostate cancer (e.g., identification of the aggressiveness or indolence of prostate cancer) in a subject. The compositions and methods include obtaining subject specific information (e.g., age, digital rectal exam (DRE) data, prostate volume, total prostate-specific antigen (PSA)) and obtaining a biological sample from a subject and determining a measurement for a panel of biomarkers in the biological sample. Compositions and methods of the invention find use in both clinical and research settings, for example, within the fields of biology, immunology, medicine, and oncology.
    Type: Application
    Filed: July 31, 2019
    Publication date: February 6, 2020
    Inventors: Amin I. Kassis, Ricardo Henao, Kirk Wojno, Geoffrey Erickson, Harry Stylli
  • Patent number: 10494675
    Abstract: This invention provides a set of biological markers that are useful for detecting cancer. This invention further provides methods of using those biological markers for the diagnosis, prognosis, or monitoring of cancer.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: December 3, 2019
    Assignee: Cell MDX, LLC
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Publication number: 20140356323
    Abstract: The present invention provides compositions comprising isolated human collagen, isolated human elastin and a pharmaceutically acceptable carrier wherein the human elastin is substantially insoluble in water with a molecular weight greater than 100 kDa. The present invention further provides methods and kits for soft tissue augmentation.
    Type: Application
    Filed: August 18, 2014
    Publication date: December 4, 2014
    Inventors: Laura E. Niklason, Yuling Li, Juliana Blum, Shannon L.M. Dahl, Geoffrey Erickson, Frank Zeigler
  • Publication number: 20120230950
    Abstract: The present invention provides compositions comprising isolated human collagen, isolated human elastin and a pharmaceutically acceptable carrier wherein the human elastin is substantially insoluble in water with a molecular weight greater than 100 kDa. The present invention further provides methods and kits for soft tissue augmentation.
    Type: Application
    Filed: May 21, 2012
    Publication date: September 13, 2012
    Applicant: Humacyte, Inc.
    Inventors: Laura Niklason, Yuling Li, Juliana Blum, Shannon Dahl, Geoffrey Erickson, Frank Zeigler
  • Patent number: 8198245
    Abstract: The present invention provides compositions comprising isolated human collagen, isolated human elastin and a pharmaceutically acceptable carrier wherein the human elastin is substantially insoluble in water with a molecular weight greater than 100 kDa. The present invention further provides methods and kits for soft tissue augmentation.
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: June 12, 2012
    Assignee: Humacyte, Inc.
    Inventors: Laura Niklason, Yuling Li, Juliana Blum, Shannon Dahl, Geoffrey Erickson, Frank Zeigler
  • Publication number: 20090028817
    Abstract: The present invention provides compositions comprising isolated human collagen, isolated human elastin and a pharmaceutically acceptable carrier wherein the human elastin is substantially insoluble in water with a molecular weight greater than 100 kDa. The present invention further provides methods and kits for soft tissue augmentation.
    Type: Application
    Filed: July 24, 2008
    Publication date: January 29, 2009
    Inventors: Laura Niklason, Yuling Li, Juliana Blum, Shannon Dahl, Geoffrey Erickson, Frank Zeigler